Wednesday, February 10, 2010, 11:42AM AEST - The Australian Stockmarket closes in 4 hours and 23 minutes.
To create a watchlist or portfolio of shares, Register

Clarient, Inc. (CLRT)

8:00AM AEST: 2.16 USD  Down 0.02 (0.92%)  
 MORE ON CLRT 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Clarient, Inc. (NCM:CLRT) Delayed quote dataEdit
Last Trade:2.16 USD
Trade Time: 8:00AM AEST
Change:Down 0.02 (0.92%)
Prev Close:2.18
Open:2.18
Bid:1.85 x 4500
Ask:2.34 x 300
1y Target Est:4.28
Day's Range:2.15 - 2.25
52wk Range:1.42 - 4.43
Volume:243,702
Avg Vol (3m):535,971
Market Cap:169.40M
P/E (ttm):N/A
EPS (ttm):-0.13
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add CLRT to Portfolio   Download Data

 HEADLINES 
Clarient CEO Ron Andrews to Present at the UBS 20th Annual Global Healthcare Services Conference in New York City
PR Newswire (Thu, Feb 4)
Clarient CEO Ron Andrews to Present at Jefferies 2010 Global Healthcare Services Conference in New York City
PR Newswire (Wed, Jan 20)
Coverage initiated on Clarient by ThinkEquity
Briefing.com (Sat, Jan 9)
Clarient CEO Ron Andrews to Present at J.P. Morgan 28th Annual Healthcare Conference in San Francisco
PR Newswire (Wed, Jan 6)
CLARIENT, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositio
EDGAR Online (Thu, Dec 24)
Stocks on the Move: Boeing, ConAgra, Jabil Circuit
at BusinessWeek (Thu, Dec 24)
Clarient buys cancer test maker Applied Genomics
AP (Tue, Dec 22)
Clarient Acquires Applied Genomics, Inc.
PR Newswire (Tue, Dec 22)
Health Care Companies With Wide Coverage Reach In Certain States Will Benefit Greatly From The $400 Billion To Be Spent By Medicaid
Wall Street Transcript (Tue, Dec 15)
Clarient, Celldex: Early Volume Plays
at TheStreet.com (Tue, Dec 15)
More Headlines for CLRT...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.08
EPS Est (in 2 years) (Dec-10) :0.06
Avg Rec (current)*:1.7
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Clarient, Inc. provides oncology diagnostics services to community pathologists, biopharmaceutical companies, and researchers in the United States. It provides various cancer diagnostic and consultative services, including technical laboratory ser...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices